LitAlert ~~ GeneLit.com

    • BRCA1/2 mutation status impact on autophagy and immune response: Unheralded target.
    • Morand S, Stanbery L, Walter A, Rocconi RP, Nemunaitis J.
    • JNCI Cancer Spectr. 2020 Aug 24; pkaa077. doi: 10.1093/jncics/pkaa077. eCollection 2020 Aug.
    • Junshi Biosciences, Impact Therapeutics to Co-Develop PARP Inhibitor Senaparib in China.
    • [No author given]
    • Precision Oncology News. 2020 Aug 20.